DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction

化学 药物反应 深度学习 人工智能 融合 药物发现 药品 计算生物学 机器学习 药理学 计算机科学 生物化学 生物 哲学 医学 语言学
作者
Jie Yu,Cheng Shi,Yiran Zhou,Ningfeng Liu,Xiaolin Zong,Zhenming Liu,Liangren Zhang
出处
期刊:Journal of Pharmaceutical Analysis [Elsevier BV]
卷期号:15 (8): 101315-101315 被引量:6
标识
DOI:10.1016/j.jpha.2025.101315
摘要

Accurate prediction of drug responses in cancer cell lines (CCLs) and transferable prediction of clinical drug responses using CCLs are two major tasks in personalized medicine. Despite the rapid advancements in existing computational methods for preclinical and clinical cancer drug response (CDR) prediction, challenges remain regarding the generalization of new drugs that are unseen in the training set. Herein, we propose a multimodal fusion deep learning (DL) model called drug-target and single-cell language based CDR (DTLCDR) to predict preclinical and clinical CDRs. The model integrates chemical descriptors, molecular graph representations, predicted protein target profiles of drugs, and cell line expression profiles with general knowledge from single cells. Among these features, a well-trained drug-target interaction (DTI) prediction model is used to generate target profiles of drugs, and a pretrained single-cell language model is integrated to provide general genomic knowledge. Comparison experiments on the cell line drug sensitivity dataset demonstrated that DTLCDR exhibited improved generalizability and robustness in predicting unseen drugs compared with previous state-of-the-art baseline methods. Further ablation studies verified the effectiveness of each component of our model, highlighting the significant contribution of target information to generalizability. Subsequently, the ability of DTLCDR to predict novel molecules was validated through in vitro cell experiments, demonstrating its potential for real-world applications. Moreover, DTLCDR was transferred to the clinical datasets, demonstrating satisfactory performance in the clinical data, regardless of whether the drugs were included in the cell line dataset. Overall, our results suggest that the DTLCDR is a promising tool for personalized drug discovery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
愿抒发布了新的文献求助10
刚刚
刚刚
小二郎的应助被和谐如风采纳,获得10
3秒前
3秒前
FashionBoy的应助被科研究极进化采纳,获得10
3秒前
Limerence完成签到,获得积分10
3秒前
4秒前
研友_xLOMQZ发布了新的文献求助30
4秒前
zzzz发布了新的文献求助10
5秒前
李爱国的应助被zww113采纳,获得10
5秒前
丹亦发布了新的文献求助10
5秒前
bkagyin的应助被kgy采纳,获得10
6秒前
7秒前
Sunyidan完成签到,获得积分10
7秒前
小蘑菇的应助被elara采纳,获得10
7秒前
8秒前
ajiang完成签到,获得积分10
9秒前
Mottri完成签到,获得积分10
11秒前
零度完成签到,获得积分10
11秒前
12秒前
清辉影的应助被漫漫采纳,获得10
12秒前
炫彩小陈发布了新的文献求助10
12秒前
lxl完成签到,获得积分10
13秒前
13秒前
咕咕嘎嘎完成签到,获得积分10
14秒前
漫漫完成签到,获得积分10
14秒前
15秒前
15秒前
15秒前
15秒前
16秒前
16秒前
努力努力再努力y完成签到 ,获得积分10
16秒前
qq1083716237发布了新的文献求助30
19秒前
研友_8DoVVZ完成签到,获得积分10
19秒前
简单老师发布了新的文献求助30
20秒前
20秒前
科研通AI6.3的应助被yj采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181888
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818887
捐赠科研通 7778145
什么是DOI,文献DOI怎么找? 3433528
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621